Palisade bio announces receipt of second milestone payment from the us crohn's and colitis foundation for development of pali-2108

- company's co-development partner, giiant pharma, inc. (“giiant”), receives funding as part of previously announced grant from the us crohn's and colitis foundation

PALI Ratings Summary

PALI Quant Ranking